CV drugs COPY Flashcards
Nitro-Bid
Long acting nitrate
Nitroglycerin ointment 2%
Admin: dosed BID 6 hrs apart w/ 10-12 hr nitrate-free interval
MONA-GAP-BA
M
Morphine sulfate -> pain relief
reserved for unacceptable pain/discomfort
has been shown to diminish antiplatelet effects
Dose: 2-5mg IV Q5-30min PRN
How long after PDE-5i’s can nitrates be given?
Avanafil (Stendra): 12hrs
Sildenafil (Viagra): 24hrs
Vardenafil: 24hrs
Tadalafil (Cialis): 48hrs
Fibrinolytic characteristics
CI:
- active bleed
- recent stroke
- severe uncontrolled HTN
ADE: bleeding
Monitor:
- Hgb
- Hct
- signs of bleeding
Integrilin
GP 2b/3b RA
Eptifibatide
ADE: bleeding, thrombocytopenia
reversible blockade- platelet function recovers in 4-8hrs
MONA-GAP-BA
A (MONA)
Aspirin
Non-enteric coated, chewable ASA 162-325mg immediately
maintenance dose 81-162 daily indefinitely
Effient Dosing
LD: 60mg PO
MD: 10 mg PO daily
Effient
P2Y12
Prasugrel
BW: BLEEDING
- not recommended in pts > 75
- stop at least 7 days prior to surgery
- avoid use if CABG likely
CI:
- active bleed
- hx of TIA or stroke
Warnings:
- bleed risk
- TTP
ADE: bleed
Notes:
- Only indicated for ACS managed with PCI
- Dispense in original container
Brillinta
P2Y12
Ticagrelor
BW:
- bleeding
- do not exceed 100mg ASA daily d/t reduced ticagrelor effectiveness
- avoid use if CABG likely
- stop 5 days before surgery
CI:
- active bleed
- Hx of intracranial hemorrhage
Warnings:
- bleed risk
- TTP
ADE:
- bleeding
- dyspnea
Plavix Dosing
LD: 300-600 mg PO
- 600 for PCI
MD: 75 mg PO daily
NitroMist, Nitrolingual
Short acting nitrate
Nitroglycerin TL spray
MONA-GAP-BA
O
Oxygen
indicated for patients w/ SaO2 sat < 90% & pts in respiratory distress
MONA-GAP-BA
G
GP 2b/3a RAs
Eptifibatide
Tirofiban
Lotrel
Benazepril/Amlodipine
Activase
Fibrinolytic
Alteplase
MOA: tissue plasminogen activator
MONA-GAP-BA
P
P2Y12 inhibitors
Clopidogrel
Prasugrel
Ticagrelor
Plavix
P2Y12
Clopidogrel
BW: test for CYP2C19 genotype (poor metabolizers will not see full effectiveness from this prodrug)
CI: active bleed
Warnings:
- bleed risk (stop 5d before planned surgery)
- do not use with omeprazole or esomeprazole
- Thrombotic thrombocytopenic purpura (TTP)
ADE:
- bleed risk
Ranexa
Anti-anginal agent
Ranolazine
Use: substitute for or addition to BB in SIHD maintenance treatment
CI: strong CYP3A4 inhibitors/inducers
Warnings:
- QT prolongation
- acute renal failure when CrCl < 30
ADE: dizziness, HA, constipation, nausea
Notes: not for acute treatment of chest pain
Isordil Titradose
Long acting nitrate
Isosorbide dinitrate
Isodur
Long acting nitrate
Isosorbide mononitrate
IR tab: dosed BID, 7 hrs apart
ER tab: daily AM dosing
Nitroglycerin clinical characteristics
CI: do not use with PDE-5i’s
ADE:
- HA
- flushing
- syncope
- hypotension/dizziness
MONA-GAP-BA
B
Beta blockers
Metoprolol or carvedilol preferred
contraindications:
- decompensated HF
- cardiogenic shock
- HR < 45 bpm
MONA-GAP-BA
A (GAP)
Anticoagulants
LMWH (enoxaparin, dalteparin)
UFH
Bivaliruden
UFH & Bivaliruden preferred in STEMI
MONA-GAP-BA
N
Nitrates
0.4mg SL NTG every 5 minutes x 3 doses
if symptoms persist -> IV NTG
Do not use IV NTG if:
- SBP < 90 mmHg
- HR < 50 bpm
- PDE-5 inhibitor use
Nitrostat
Short acting nitrate:
Nitroglycerin SL tablets
Store in original amber glass bottle
ReoPro
GP 2b/3a RA
Abciximab
ADE: bleeding, thrombocytopenia
irreversible blockade- platelet function recovers in 24-48 hrs
only recommended in ACS patients receiving PCI +/- stent
Aggrastat
GP 2b/3b RA
Tirofiban
ADE: bleeding, thrombocytopenia
reversible blockade- platelet function recovers in 4-8hrs
GoNitro
Short acting nitrate
Nitroglycerin SL powder
TNKase
Fibrinolytic
Tenecteplase
Nitro-Dur
Long acting nitrate
Nitroglycerin transdermal patch
Admin: wear for 12-14hrs, off for 10-12hrs; rotate sites
Preferred stable angina maintenance treatment in HFrEF
Isosorbide dinitrate + Hydralazine
Long acting nitrates notes
Require a 10-12 hr nitrate-free interval to reduce tolerance
Patch: wear for 12-14hrs, off for 10-12hrs; rotate sites
Ointment: dosed BID 6 hrs apart w/ 10-12 hr nitrate-free interval
MONA-GAP-BA
A (BA)
ACE inhibitor
start within first 24hrs & continue indefinitely in pts w/ LVEF < 40%, HTN, diabetes, or stable CKD.
use ARB if pt is ACE intolerant
do not use IV ACE within the first 24 hrs due to risk of hypotension
Brilinta Dosing
LD: 180 mg PO
MD: 90mg PO BID x 1 year then 60mg PO BID